Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
23.75
+0.83 (3.62%)
Oct 8, 2025, 12:12 PM EDT - Market open

Castle Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
6897465816201,1031,622
Upgrade
Market Cap Growth
-21.07%28.53%-6.38%-43.76%-32.00%176.41%
Upgrade
Enterprise Value
4264933663687401,461
Upgrade
Last Close Price
22.9226.6521.5823.5442.8767.15
Upgrade
PE Ratio
-40.91----
Upgrade
PS Ratio
1.882.252.644.5311.7225.89
Upgrade
PB Ratio
1.461.641.481.552.683.90
Upgrade
P/TBV Ratio
1.892.132.122.273.423.90
Upgrade
P/FCF Ratio
19.2520.43---317.18
Upgrade
P/OCF Ratio
10.6411.51---164.43
Upgrade
EV/Sales Ratio
1.231.491.662.697.8623.33
Upgrade
EV/EBITDA Ratio
21.9320.00----
Upgrade
EV/EBIT Ratio
-56.90----
Upgrade
EV/FCF Ratio
12.3413.50---285.78
Upgrade
Debt / Equity Ratio
0.080.060.040.030.02-
Upgrade
Debt / EBITDA Ratio
1.660.96----
Upgrade
Debt / FCF Ratio
1.080.72----
Upgrade
Asset Turnover
0.670.680.490.300.210.22
Upgrade
Inventory Turnover
8.047.497.5510.677.475.61
Upgrade
Quick Ratio
6.476.975.907.8113.9420.24
Upgrade
Current Ratio
6.857.296.208.0914.2220.58
Upgrade
Return on Equity (ROE)
-2.15%4.31%-14.54%-16.56%-7.56%-4.11%
Upgrade
Return on Assets (ROA)
-2.79%1.10%-9.43%-12.52%-5.56%-1.88%
Upgrade
Return on Capital (ROIC)
-3.06%1.22%-10.37%-13.68%-6.00%-2.00%
Upgrade
Return on Capital Employed (ROCE)
-1.80%----
Upgrade
Earnings Yield
-1.42%2.44%-9.89%-10.82%-2.84%-0.63%
Upgrade
FCF Yield
5.20%4.90%-3.31%-7.62%-2.04%0.32%
Upgrade
Buyback Yield / Dilution
-4.13%-9.15%-2.87%-3.65%-32.80%-118.63%
Upgrade
Updated Aug 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q